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Z O S T E R V I R U S 
L . Ivanova, B. Halova*, V. Gardevska 
Department of Microbiology, Medical University of Varna, Varna 
and ^Institute of Hygiene & Epidemiology, Sofia 
The degree of seropositiveness against Varicella-zoster virus (VZV) were 
established by examination of 737 single serum samples from clinically healthy donors 
aged 1-60 years by using CF-test. Comparatively, 91 of them were studied by EL1SA 
(Behring-Germany, Ensygnost-Varicella-Zoster). Additionally, 37 single serum samples 
of patients with clinical symptoms of herpes zoster were examined by CF-test. The results 
of the healthy population showed a mean seroprevalence of 48,98 % by CF-test and of 
60,44 % by ELISA. The difference of seroprevalence of healthy and ill individuals (with 
typical clinical signs) in matched age intervals was considerable only with patients 
suffering from herpes zoster. 
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Varicella-zoster virus ( V Z V ) is 
a member of the Herpesviridae 
family. The primary infection is 
manifested as varicella (leshtenka, 
Bulgarian folk name). According to 
bibliographic data available (10), 
somewhat about 3,5 million patients 
are registered annually in the U S A , 95 
% of them being children (1-14 years 
old) and only 2 % adults (over 20 
years old). Bulgaria represents also a 
pediatric tendency in the disease (3). 
After primary infection the virus is 
latent in dorsal stem ganglia and 
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cranial nerve ones but its reactivation 
later on leads to herpes zoster. The 
same is with rest members of this 
family; one of the explanations of this 
phenomenon is a suggested 
incomplete immunity not being 
sufficient to eliminate the virus away 
from the patient's organism. The latter 
transfers into a latent status and its 
reactivation in later terms is 
associated with temporary dysbalance 
or total lack of cellular immunity 
(7,8). 
The host immune response 
towards VZV-infection is not yet 
clear. Early humoral immune reaction 
in most patients is registered about 6 
days after the beginning of the 
primary infection with formation of 
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IgM and IgG anti-VZV-antibodies 
established by immunofluorescent or 
E L I S A techniques. It persists for 
many years after the acute infection 
(5,11,15). The seroprevalence is of 96 
% in North America (9,14), 90 % in 
South Africa but the age 
representation is increased gradually 
and about the age of 60 years it is 
practically 100% (12). 
The present study is our attempt 
to compare the level of V Z V -
seroprevalence in healthy individuals 
and the induction of humoral immune 
response in patients with varicella or 
herpes zoster. 
M A T E R I A L AND METHODS 
A total of 737 single serum tests 
of clinically healthy subjects aged 
between 1 and 60 years divided into 
age groups were examined (Fig. 1). 
Some 37 single serum tests of patients 
with varicella examined 7 days to 1 
month after the onset of characteristic 
rush on the skin were studied along 
with 33 single serum tests of patients 
with clinically manifested signs of 
herpes zoster examined after the 
manifestations of typical clinical 
symptoms. 
The following methods were 
applied: CF-test was used to detect 
anti-VZV-antibodies the micro-
method (2,6) being reported in our 
previous study (1). Values of titres of 
CF-antibodies under 1:4 were 
considered negative, whereas values 
of those titres over or equal to 1:4 
were considered positive for antiviral 
immune reaction. A soluble antigen 
(provided by NDOPD-Sofia and 
Behring-Germany) was used in our 
study. Other authors (13) accepted 
titres of 1:2 (over or equal) as a 
positive sign may be due to the 
weaker sensitiveness of test. E L I S A -
technique was applied for 
examination of 91 healthy donors 
with tests of Behring-Germany 
(Ensygnost-Varicella/Zoster). This 
method included a dilution of the 
serum sample 1:44 which, in turn, 
reacted with a standard antigen 
(preliminarily loaded) and control 
antigen (negative) both from human 
cell cultures and both inactivated in 
advance. The registration of the 
results was performed on Titertek 
Uniskan-Finland at 405 nm. The 
positive reaction of the serum test was 
a marker of previous VZV-infection. 
RESULTS AND DISCUSSION 
CF-test with antigens from 2 
different firms does not show 
considerably different results. F ig . l 
presents the distribution of 737 
clinically healthy individuals 
according to their age and percentage 
of seropositiveness (antibody titres 
over or equal to 1:4). A consequent 
increase of the level of 
seropositiveness associated with the 
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Comparative study of patients. 
Table 1 
Patients' distribution according to titres of antibodies against VZV (by CF-test) 
Contingent varicella patients herpes zoster patients 
Titre 
n % n % 
< 1:4 16 43,24 5 15,15 
1 4 7 18,92 8 24,24 
1 8 2 5,41 1 3,03 
1 16 3 8,11 6 18,18 
1 32 8 21,62 3 9,09 
1 64 1 2,70 6 18,18 
1 128 4 12,12 
total 37 100 33 99,99 
age is registered with a peak at 4-7 
year age group. Therefore, this first 
result of sudden increase of the 
infection frequency is most probably 
due to the tradition that children are 
collected in kindergardens in this age. 
The literature data show that such a 
peak is established in the age group of 
5-9 years (3,10). Further with age the 
level of seropositiveness is preserved 
with some slight ups and downs. 
Another peak, in the age group of 26-
30 years, is registered and this result 
may be is due to the increased 
frequency or reactivation of the latent 
virus and its clinical manifestation in 
herpes zoster. The seropositiveness is 
of 66,66 % in the age group of 51-60 
years, whereas the mean one for the 
whole examined population is of 
48,98 %. Some 55 (60,44 % ) of all 91 
examined by E L I S A clinically healthy 
donors are positive. The difference of 
seroprevailance could be explained 
with higher sensitiveness of this test 
to compare to CF-test, confirmed by 
other authors, too (13). 
The comparative study of 37 
patients with varicella establishes an 
age range between 1 and 22 as 9 of 
them (24,32 ) are 1-3 years old, 19 
(51,35 ) are 4-7, 3 (8,11 % ) are 8-10, 
4 (10,82 % ) are 11-14 years old, while 
in the age groups of 15-18 and 19-22 
years there is one patient each (2,7 
% ) . The seropositiveness (by CF-test) 
is of 56,76 % as compared to the 
mean one (40,4 5%) in healthy 
individuals from the same age group. 
Therefore, the seroprevalence of 
varicella patients does no differ 
considerably from that of the healthy 
population (p > 0,05). 
When analyzing the results it is 
essential to have in mind the time for 
serum sample collection. Patients 
examined by CF-test in the first 7-19 
days after beginning of clinical 
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F/g. / . Healthy donors' distribution according 
to age and percentage seropositiveness 
against VZV studied by CF-test 
symptoms have no antibodies. Titres 
of 1:4 - 1:16 are registered only 20 
days after the onset of the disease. 
High titres (1:32 - 1:64) are 
established in reconvalescent patients, 
1 or more months after the beginning 
of clinical symptoms. This means that 
in order to be precise in our etiologic 
diagnosis by CF-test we need a 
double serum sample in 1-month 
interval. A 4-time seroconversion of 
the reconvalescent serum test is an 
undoubtful indication of the disease. 
Some 33 patients with herpes 
zoster are aged between 19 and 60 
years: 7 from them (21,22 % ) are 19-
25 years old, 26 (78,78 % ) are 26-60. 
The seroprevalence (CF-test) is of 
84,84 % to compare to 55,89 % of 
mean seroprevalence in healthy 
individuals of the same age group, p < 
0,001. 
The considerable difference of 
seroprevalence between patients with 
varicella and herpes zoster (p < 0,01) 
is another proof that herpes zoster is a 
manifestation of the reactivation of a 
latent VZV-infection and the 
formation of high titre antibodies for 
shorter period after the clinical 
symptoms is undoubtfully registered. 
In conclusion, the seropre­
valence towards V Z V increases with 
the age of examined individuals 
reaching up to 66,66 % in the age 
group of 51-60 years, whereas the 
mean seroprevalence of the whole 
population under our study is of 48,98 
% The age-associated illness 
coincides with the registered peaks of 
healthy subjects in our study. 
Seroprevalence established by E L I S A 
is higher than that by CF-test due to 
higher sensitivity of the former (13). 
The difference of seroprevalence of 
healthy subjects and patients with 
typical clinical symptoms in one and 
the same age range is considerable 
only with patients suffering from 
herpes zoster (p < 0,001). 
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Сравнително проучване носителството на антитела срещу 
Varicella-zoster virus при здрави и болни индивиди 
Л. Иванова, Б. Халова*, В. Гърдевска 
Катедра по микробиология, Медицински университет - Варна и *ХЕИ-София, 
София 
Резюме: Степента на серопозитивност спрямо varicella-zoster virus ( V Z V ) бе 
установена при изследване на 737 единични серумни проби от клинично здрави 
лица на възраст от 1 до 60 г. с комплемент-фиксиращ тест (CF-тест). В сравнителен 
аспект са изследвани 91 от здравите лица с ELISA-тест на фирмата Behring (ФРГ) 
(Ensygnost-Varicella/Zoster). Изследвани са 37 единични серумни проби от 
пациенти с клинични данни за варицела и 33 единични серумни проби от болни с 
клинични данни за херпес зостер с помощта на CF-тест. Резултатите от 
изследването на здравата популация показват средна серопревалентност от 48,98 % 
при CF-тест и 60,44 % - при ELISA-тест. Разликата в серопревалентността на 
здравите и болните с характерна клинична симптоматика индивиди в еднакъв 
възрастов диапазон е съществена само при болните с херпес зостер. 
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